hugel, inc. - Medication Listings
Browse 2 medications manufactured by hugel, inc.. Open a product record to review dosage forms, strengths, packaging, and related navigation.
LetibotulinumtoxinA-wlbg is an acetylcholine release inhibitor and a neuromuscular blocking agent. LetibotulinumtoxinA-wlbg is a 900 kDa botulinum toxin type A, produced from fermentation of Clostridium botulinum . LETYBO (letibotulinumtoxinA-wlbg) for injection is supplied as a sterile, preservative-free, white, freeze-dried powder in a single-dose vial for intramuscular use after reconstitution. Each vial contains either 50 Units of letibotulinumtoxinA-wlbg, albumin human (0.25 mg) and sodium chloride (0.45 mg); or 100 Units of letibotulinumtoxinA-wlbg, albumin human (0.5 mg) and sodium chloride (0.9 mg).
Uses • helps prevent sunburn • if used as directed with other sun protection measures (see Directions) decreases the risk of skin cancer and early skin aging caused by the sun
About hugel, inc.
This collection groups medications in our database that are associated with hugel, inc.. It currently includes 2 matching listings. Open any result to review label-backed details such as dosage forms, ingredients, packaging, and related navigation.
What You Can Review
Use this page to move from manufacturer-level browsing into specific drug detail pages. Each listing gives you a path to the underlying product record and related brand, generic, or substance pages.
Related Navigation
Some products may appear in multiple brand or generic contexts. Check individual listings for the exact naming used in the product data and to continue exploring.
Important Safety Information
Always consult with a qualified healthcare provider before starting, stopping, or changing any medication. The information provided on this page is for educational purposes only and does not constitute medical advice. Read medication labels and package inserts carefully before use.